These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 18926274)

  • 1. Substitution treatment in Malaysia.
    Noordin NM; Merican MI; Rahman HA; Lee SS; Ramly R
    Lancet; 2008 Sep; 372(9644):1149-50. PubMed ID: 18926274
    [No Abstract]   [Full Text] [Related]  

  • 2. Maintenance therapy for opioid addiction with methadone, LAAM and buprenorphine: the Emperor's New Clothes Phenomenon.
    Stimmel B
    J Addict Dis; 2001; 20(4):1-5. PubMed ID: 11760922
    [No Abstract]   [Full Text] [Related]  

  • 3. [Can substitution practices be indicated in withdrawal programs for heroin addicts?].
    Boissonnas A
    Ann Med Interne (Paris); 1994 Nov; 145 Suppl 3():96-7. PubMed ID: 7880042
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of heroin addicts using buprenorphine.
    Kosten TR; Morgan C; Kleber HD
    Am J Drug Alcohol Abuse; 1991 Jun; 17(2):119-28. PubMed ID: 1862786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparative value of buprenorphine and methadone].
    Reisinger M
    Ann Med Interne (Paris); 1994 Nov; 145 Suppl 3():23-5. PubMed ID: 7880007
    [No Abstract]   [Full Text] [Related]  

  • 6. Regarding naltrexone for probationers and parolees.
    Stancliff S
    J Subst Abuse Treat; 2007 Mar; 32(2):217-8; author reply 218-9. PubMed ID: 17306730
    [No Abstract]   [Full Text] [Related]  

  • 7. Buprenorphine for benzodiazepine-abusing heroin addicts.
    KOSTEN TR
    Am J Psychiatry; 1994 Jan; 151(1):151. PubMed ID: 8267120
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacotherapeutic environments for substance use disorders.
    Gardner TJ; Kosten TR
    Am J Drug Alcohol Abuse; 2007; 33(5):627-9. PubMed ID: 17891655
    [No Abstract]   [Full Text] [Related]  

  • 9. Cost-effectiveness of buprenorphine and naltrexone treatments for heroin dependence in Malaysia.
    Ruger JP; Chawarski M; Mazlan M; Ng N; Schottenfeld R
    PLoS One; 2012; 7(12):e50673. PubMed ID: 23226534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Buprenorphine treatment for concurrent heroin and cocaine dependence: phase I study.
    Mendelson JH; Mello NK; Teoh SK; Kuehnle J; Sintavanarong P; Dooley-Coufos K
    NIDA Res Monogr; 1990; 105():196-202. PubMed ID: 1875999
    [No Abstract]   [Full Text] [Related]  

  • 11. [Role of LAAM, methadone and naltrexone in the care of opiate dependence. Experience in Portugal].
    Patricio LD; Miguel N
    Ann Med Interne (Paris); 1994 Nov; 145 Suppl 3():28-30. PubMed ID: 7880010
    [No Abstract]   [Full Text] [Related]  

  • 12. A literature review of international implementation of opioid substitution treatment in prisons: equivalence of care?
    Larney S; Dolan K
    Eur Addict Res; 2009; 15(2):107-12. PubMed ID: 19182485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quality of life among heroin users on buprenorphine versus methadone maintenance.
    Ponizovsky AM; Grinshpoon A
    Am J Drug Alcohol Abuse; 2007; 33(5):631-42. PubMed ID: 17891656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Economic evaluation: a comparison of methadone versus buprenorphine for opiate substitution treatment.
    Maas J; Barton G; Maskrey V; Pinto H; Holland R
    Drug Alcohol Depend; 2013 Dec; 133(2):494-501. PubMed ID: 23962419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Naltrexone-assisted rapid methadone discontinuation: a pilot study.
    Camarasa X; Khazaal Y; Besson J; Zullino DF
    Eur Addict Res; 2007; 13(1):20-4. PubMed ID: 17172775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is naltrexone a cure for heroin dependence?
    Hall WD; Wodak A
    Med J Aust; 1999 Jul; 171(1):9-10. PubMed ID: 10451663
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical evaluation of naltrexone treatment of opiate-dependent individuals. Report of the National Research Council Committee on Clinical Evaluation of Narcotic Antagonists.
    Arch Gen Psychiatry; 1978 Mar; 35(3):335-40. PubMed ID: 365122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Reduction in the number of lethal heroin overdoses in France since 1994. Focus on substitution treatments].
    Lepère B; Gourarier L; Sanchez M; Adda C; Peyret E; Nordmann F; Ben Soussen P; Gisselbrecht M; Lowenstein W
    Ann Med Interne (Paris); 2001 Apr; 152 Suppl 3():IS5-12. PubMed ID: 11435989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pregnancy, abortion and delivery in a cohort of heroin dependent patients treated with drug substitution (methadone and buprenorphine) in Aquitaine].
    Auriacombe M; Afflelou S; Lavignasse P; Lafitte C; Roux D; Daulouède JP; Tignol J
    Presse Med; 1999 Jan; 28(4):177. PubMed ID: 10071631
    [No Abstract]   [Full Text] [Related]  

  • 20. Prospective randomised comparative study of the effect of buprenorphine, methadone and heroin on the course of pregnancy, birthweight of newborns, early postpartum adaptation and course of the neonatal abstinence syndrome (NAS) in women followed up in the outpatient department.
    Binder T; Vavrinková B
    Neuro Endocrinol Lett; 2008 Feb; 29(1):80-6. PubMed ID: 18283247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.